Alerts will be sent to your verified email
Verify Email
EIKO
|
Eiko Lifesciences
|
Deep Polymers
|
Archit Organosys
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.81 % | 10.81 % | 10.26 % |
|
5yr average Equity Multiplier
|
2.12 | 1.66 | 1.83 |
|
5yr Average Asset Turnover Ratio
|
0.56 | 0.97 | 1.03 |
|
5yr Avg Net Profit Margin
|
-3.7 % | 6.51 % | 5.26 % |
|
Price to Book
|
1.28 | 0.82 | 1.11 |
|
P/E
|
17.73 | 15.47 | 9.65 |
|
5yr Avg Cash Conversion Cycle
|
61.48 Days | 130.23 Days | 1.73 Days |
|
Inventory Days
|
214.38 Days | 65.45 Days | 13.02 Days |
|
Days Receivable
|
57.98 Days | 95.58 Days | 65.79 Days |
|
Days Payable
|
248.22 Days | 35.55 Days | 68.34 Days |
|
5yr Average Interest Coverage Ratio
|
-0.09 | 20.96 | 4.29 |
|
5yr Avg ROCE
|
-109.51 % | 11.45 % | 12.71 % |
|
5yr Avg Operating Profit Margin
|
-9.68 % | 11.58 % | 10.36 % |
|
5 yr average Debt to Equity
|
0.3 | 0.47 | 0.43 |
|
5yr CAGR Net Profit
|
60.2 % | 23.36 % | -14.95 % |
|
5yr Average Return on Assets
|
-4.56 % | 6.29 % | 5.4 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
37.17 % | 65.57 % | 65.86 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
14.14 % | 2.78 % | 4.22 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Eiko Lifesciences
|
Deep Polymers
|
Archit Organosys
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|